INTAL AEROSOL 5MG/DOSE

Indications and usage

Prevention and treatment of bronchial asthma (including physical stress asthma) in children and adults.

Contraindications

Hypersensitivity to the drug.

Dosage and administration

Dosed aerosol for inhalation adults (including the elderly) and children prescribed in the initial dose of 2 inhalations 4 times / day. When an optimal therapeutic effect is achieved, it is possible to switch to a maintenance dose that ensures optimal control of the disease.The dose of the drug can be increased to 2 inhalations 6-8 times / day in cases of more severe disease, as well as during periods of enhanced antigenic exposure. Additionally, the drug can be used immediately before exercise for the prevention of physical stress asthma.

Inhalation of content capsules with powder for inhalation It is carried out with the help of a spinhaler activated by the patient's breathing effort during inhalation. Intal is not effective when swallowing a capsule. The action of the drug develops when it is directly injected into the respiratory tract. Adults (including the elderly) and children the drug is prescribed in 1 caps. 4 times / day: 1 caps. at night, 1 in the morning and 2 in the interval, with an interval of 3-6 hours. The need to increase the dose to 6-8 caps / day may occur in cases of more severe disease, as well as during periods of enhanced antigenic exposure. In addition, the drug can be used immediately before exercise for the prevention of physical stress asthma or prior to intended contact with other trigger factors.
When a stable therapeutic effect is achieved, a transition to the minimum maintenance dose is possible, ensuring sufficient control of the disease.

With concomitant therapy with bronchodilators they must be taken before inhalation Intala.
With concomitant glucocorticoid therapy the addition of Intal may allow to reduce the maintenance dose or completely refuse to take GCS.During the last dose reduction, the patient should be under the close supervision of a doctor: the rate of dose reduction should not exceed 10% per week. Increasing the dose of corticosteroids may be required if the symptoms of the disease, concomitant infection, severe antigenic effects or stress increase. If it was possible to reduce the dose of GCS, Intal should be used until hormone therapy is resumed.

If necessary, the termination of the use of Intal withdrawal of the drug produced gradually over 1 week. Symptoms may be resumed during dose reduction.

Adverse reactions

From the upper respiratory tract: symptoms of irritation of the upper respiratory tract, cough, short-term symptoms of bronchospasm; the phenomenon of pronounced bronchospasm with a decrease in the indices of the function of external respiration is extremely rarely noted (in such cases, the administration of the drug is stopped and no longer resumes).

Pregnancy and breastfeeding

Intal is used with caution during pregnancy and lactation.

Special notes

Intal is not a drug for the relief of asthma attacks.
The patient should be instructed on the need for regular use of Intal as opposed to taking medications occasionally used to reduce bronchospasm.
Bromhexine and Ambroxol should not be used simultaneously in an inhalation solution of cromoglicic acid.
The contents of the cartridge is under pressure, so it cannot be pierced or exposed to fire, even if it is empty.

Dosed aerosol should be stored at a temperature not exceeding 30 ° C, but not in the refrigerator; avoid direct sunlight. Shelf life - 4 years.
Powder for inhalation capsules should be stored at a temperature not exceeding 30 ° C; do not freeze.
Shelf life - 5 years.

Intal